A real-world study of palbociclib plus endocrine therapy with or without a short course chemotherapy in the first-line treatment of HR-positive HER2-negative metastatic breast cancer
一项真实世界研究,评估帕博西尼联合内分泌治疗(加或不加短期化疗)一线治疗HR阳性HER2阴性转移性乳腺癌的疗效
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1512496
Li, Xiangjun; Song, Yuhua; Lv, Meng; Wang, Yongmei; Gao, Xueqiang; Ma, Tianyi; Ma, Teng; Liu, Changgen; Sun, Xinyi; Wang, Haibo; Mao, Yan